Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical‐controlled, multicenter, double‐blind study

201486 citationsJournal Articlehybrid Open Access

Authors

Lacosamide 400 mg/day monotherapy was effective, with a favorable safety profile in patients with focal epilepsy.

Good health and well-being

Published in: Epilepsia

Volume 55, Issue 7, pp. 1088-1098

Field-Weighted Citation Impact: 9.08